Pinnacle Financial Group, Inc.’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$483K Buy
+8,727
New +$471K 0.05% 282

Other funds holding CRSP

Pinnacle Financial Group, Inc.'s CRSP Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in CRISPR Therapeutics (CRSP) in Q3 2026: 8,727 shares worth $483K. The stake represents 0.05% of the portfolio and ranks #282 among its holdings.

503 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 8,727 shares of CRISPR Therapeutics worth $483K as of Q3 2026.
  • CRISPR Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • CRISPR Therapeutics made up 0.05% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #282 holding.
  • 503 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.